Abstract
Updated Efficacy Results from XELOX1/NO16966, a Randomized Phase 3 Trial inFirst-Line Metastatic Colorectal Cancer
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have